Thomas Kuhn

Microsoft Office 365 Amazon AWS Google Font API Mobile Friendly Apache Data Analytics Remote Basis AI

type 2 diabetes metabolic diseases nash ampk nonalcoholic steatohepatitis direct adenosine monophosphateactivated protein kinase activator biotechnology life sciences biotechnology research biopharmaceutical chronic diseases non-alcoholic steatohepatitis rare diseases imeglimin twymeeg pxl065 pxl770 ampk activator metabolic pathophysiology clinical development drug development pipeline energy metabolism clinical trials disease-modifying mitochondrial dysfunction therapeutic area partnerships royalties sales-based payments phase 2 trial japan strategic collaborations leadership research & development patient access life-cycle management clinical programs inherited metabolic disorders adrenoleukodystrophy adrenomyeloneuropathy deuterium-modified tzd financial results investor relations euronext regulatory affairs global regulatory metabolic pathways scientific expertise disease targets market access sales forecast clinical candidates long-term partnerships pharmaceutical industry innovation health care health wellness & fitness hospital & health care